Back to everyone

Nick Dixon‑Clegg

Partner, Head of Independent Investments

Nick Dixon-Clegg

Nick joined Oxford Science Enterprises in July 2020, bringing over a decade of investment and corporate finance experience.

Nick leads the Independent Investments Team, working exclusively with established portfolio companies that have developed a significant degree of independence from OSE. He manages OSE’s investments in these companies, supports their continued growth and development, and is responsible for investing fresh OSE capital into them.

Prior to OSE, Nick was an Investment Principal at Valiance, a MedTech-focused venture capital firm. He has also held roles as a private equity investor at Nordic Capital and as an investment banker at Bank of America Merrill Lynch.

Nick holds a Triple First Class MA (Cantab) in Natural Sciences from the University of Cambridge.

Nick sits on the board of

  • BehaVR
  • Bibliu
  • Dark Blue Therapeutics
  • EnzBond
  • IngenOx Therapeutics
  • Metaboards
  • Opsydia

Nick is an observer on the board of

  • Genomics
  • Scenic Biotech

Meet all our

Specialists

Alex Hammacher
Alex HammacherHead of Strategic Operations & Corporate Finance
Athene Blakeman
Athene BlakemanHead of Legal
Emily Matthews
Emily MatthewsResponsible Investment & ESG Manager
Jim Wilkinson
Jim WilkinsonChief Financial Officer
Lilly Bussmann
Lilly BussmannHead of Network
Lisa Bedwell
Lisa BedwellHead of Marketing
Oliver Mahony
Oliver MahonyInvestment Manager
Pete Wilder
Pete WilderHead of Property
Polly Elvin
Polly ElvinHead of Investor Relations & Co-Investors
Sarah Shackelton
Sarah ShackeltonChief Talent Officer
Sive Ozer
Sive OzerLegal Counsel
Thomas Capon
Thomas CaponInvestment Manager